CD300a anticorps (PE-Cy5)

N° du produit ABIN1434939

Cet anticorps anti-CD300a est un anticorps Lapin Polyclonal détectant CD300a dans WB. Adapté pour Humain.

Aperçu rapide pour CD300a anticorps (PE-Cy5) (ABIN1434939)

Antigène: CD300a (CD300A)

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CD300a est conjugé à/à la PE-Cy5

Application: Western Blotting (WB)

Détail du produit anti-CD300a anticorps (PE-Cy5)

Réactivité croisée: Humain

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human CD300A

Isotype: IgG

Information d'application

Indications d'application: FCM(1:100-500)
Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur CD300a

Antigène: CD300a (CD300A)

Autre désignation: CD300A

Sujet:

Synonyms: CD300A, CMRF35-like molecule 8, CLM-8, CD300 antigen-like family member A, CMRF-35-H9, CMRF35-H9, IRC1/IRC2, Immunoglobulin superfamily member 12, IgSF12, Inhibitory receptor protein 60, IRp60, NK inhibitory receptor, CMRF35H, CD300C, CMRF35-like molecule 6, CLM-6, CD300 antigen-like family member C, CMRF35-A1, CMRF-35, Immunoglobulin superfamily member 16, IgSF16, CMRF35A1

Background: Inhibitory receptor which may contribute to the down-regulation of cytolytic activity in natural killer (NK) cells, and to the down-regulation of mast cell degranulation.

Poids moléculaire: 60 kDa

ID gène: 11314

UniProt: Q9UGN4

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process